Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980674180> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1980674180 endingPage "534" @default.
- W1980674180 startingPage "530" @default.
- W1980674180 abstract "Although several lipid-modifying drug (LMD) treatments and strategies are available to successfully manage patients at risk for cardiovascular events, the benefits of drug treatment can be realized only if these therapies are continued on a long-term basis. Previous observational studies examining rates of discontinuation with LMDs are not generalizable to current clinical practice in the United States. In this study, the discontinuation of newly initiated LMD classes in recent clinical practice was compared in a geographically diverse, commercially insured United States population. Administrative claims from the Ingenix Lab/Rx Database were used to identify patients aged >or=20 years who were newly prescribed statins, extended-release niacin, fibrates, bile acid sequestrants, or ezetimibe from January 1, 2001, to June 30, 2003. An LMD class was considered discontinued if a patient did not receive a prescription from the same LMD class within 180 days of the most recent prescription expiration date. The median time to discontinuation was 8.2 months in the bile acid sequestrant group, followed by 12 months in the extended-release niacin group, 17.4 months in the fibrate group, and 27.5 months in the statin group. By the end of 1 year, the adjusted cumulative incidence of discontinuation was 68.3% in bile acid sequestrant users, 55.4% in extended-release niacin users, 39.9% in fibrate users, 33.0% in ezetimibe users, and 28.9% in statin users (p <0.001 for all LMD classes vs statins). In conclusion, despite the changes in lipid treatment paradigms and the importance of long-term lipid therapy, this study found high discontinuation rates of LMD classes in recent United States clinical practice." @default.
- W1980674180 created "2016-06-24" @default.
- W1980674180 creator A5057780720 @default.
- W1980674180 creator A5071956599 @default.
- W1980674180 creator A5082531351 @default.
- W1980674180 creator A5086954528 @default.
- W1980674180 date "2007-02-01" @default.
- W1980674180 modified "2023-09-30" @default.
- W1980674180 title "Discontinuation of Lipid Modifying Drugs Among Commercially Insured United States Patients in Recent Clinical Practice" @default.
- W1980674180 cites W116577846 @default.
- W1980674180 cites W1603605306 @default.
- W1980674180 cites W2017509671 @default.
- W1980674180 cites W2137740753 @default.
- W1980674180 doi "https://doi.org/10.1016/j.amjcard.2006.08.063" @default.
- W1980674180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17293198" @default.
- W1980674180 hasPublicationYear "2007" @default.
- W1980674180 type Work @default.
- W1980674180 sameAs 1980674180 @default.
- W1980674180 citedByCount "101" @default.
- W1980674180 countsByYear W19806741802012 @default.
- W1980674180 countsByYear W19806741802013 @default.
- W1980674180 countsByYear W19806741802014 @default.
- W1980674180 countsByYear W19806741802015 @default.
- W1980674180 countsByYear W19806741802016 @default.
- W1980674180 countsByYear W19806741802017 @default.
- W1980674180 countsByYear W19806741802018 @default.
- W1980674180 countsByYear W19806741802019 @default.
- W1980674180 countsByYear W19806741802020 @default.
- W1980674180 countsByYear W19806741802021 @default.
- W1980674180 countsByYear W19806741802022 @default.
- W1980674180 countsByYear W19806741802023 @default.
- W1980674180 crossrefType "journal-article" @default.
- W1980674180 hasAuthorship W1980674180A5057780720 @default.
- W1980674180 hasAuthorship W1980674180A5071956599 @default.
- W1980674180 hasAuthorship W1980674180A5082531351 @default.
- W1980674180 hasAuthorship W1980674180A5086954528 @default.
- W1980674180 hasBestOaLocation W19806741801 @default.
- W1980674180 hasConcept C126322002 @default.
- W1980674180 hasConcept C23131810 @default.
- W1980674180 hasConcept C2426938 @default.
- W1980674180 hasConcept C2776839432 @default.
- W1980674180 hasConcept C2776933373 @default.
- W1980674180 hasConcept C2778657065 @default.
- W1980674180 hasConcept C2778715236 @default.
- W1980674180 hasConcept C2778858636 @default.
- W1980674180 hasConcept C2780092750 @default.
- W1980674180 hasConcept C71924100 @default.
- W1980674180 hasConcept C98274493 @default.
- W1980674180 hasConceptScore W1980674180C126322002 @default.
- W1980674180 hasConceptScore W1980674180C23131810 @default.
- W1980674180 hasConceptScore W1980674180C2426938 @default.
- W1980674180 hasConceptScore W1980674180C2776839432 @default.
- W1980674180 hasConceptScore W1980674180C2776933373 @default.
- W1980674180 hasConceptScore W1980674180C2778657065 @default.
- W1980674180 hasConceptScore W1980674180C2778715236 @default.
- W1980674180 hasConceptScore W1980674180C2778858636 @default.
- W1980674180 hasConceptScore W1980674180C2780092750 @default.
- W1980674180 hasConceptScore W1980674180C71924100 @default.
- W1980674180 hasConceptScore W1980674180C98274493 @default.
- W1980674180 hasIssue "4" @default.
- W1980674180 hasLocation W19806741801 @default.
- W1980674180 hasLocation W19806741802 @default.
- W1980674180 hasOpenAccess W1980674180 @default.
- W1980674180 hasPrimaryLocation W19806741801 @default.
- W1980674180 hasRelatedWork W1483346782 @default.
- W1980674180 hasRelatedWork W1980674180 @default.
- W1980674180 hasRelatedWork W1998661484 @default.
- W1980674180 hasRelatedWork W2036968137 @default.
- W1980674180 hasRelatedWork W2081137004 @default.
- W1980674180 hasRelatedWork W2116615635 @default.
- W1980674180 hasRelatedWork W2147213389 @default.
- W1980674180 hasRelatedWork W2373572815 @default.
- W1980674180 hasRelatedWork W3027264299 @default.
- W1980674180 hasRelatedWork W3034636523 @default.
- W1980674180 hasVolume "99" @default.
- W1980674180 isParatext "false" @default.
- W1980674180 isRetracted "false" @default.
- W1980674180 magId "1980674180" @default.
- W1980674180 workType "article" @default.